IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $132,173,000 | +463.0% | 1,554,427 | +134.6% | 0.14% | +382.1% |
Q2 2020 | $23,478,000 | +307.0% | 662,454 | +54.8% | 0.03% | +211.1% |
Q1 2020 | $5,769,000 | -50.8% | 427,929 | -22.7% | 0.01% | -30.8% |
Q4 2019 | $11,715,000 | +506.7% | 553,638 | +280.2% | 0.01% | +550.0% |
Q3 2019 | $1,931,000 | +160.2% | 145,604 | +172.2% | 0.00% | +100.0% |
Q2 2019 | $742,000 | -30.0% | 53,487 | -3.1% | 0.00% | 0.0% |
Q1 2019 | $1,060,000 | +23.8% | 55,174 | -8.0% | 0.00% | 0.0% |
Q4 2018 | $856,000 | -55.1% | 60,000 | -34.4% | 0.00% | -66.7% |
Q3 2018 | $1,905,000 | +1.2% | 91,464 | +14.9% | 0.00% | 0.0% |
Q2 2018 | $1,883,000 | -36.5% | 79,574 | -60.8% | 0.00% | -25.0% |
Q1 2018 | $2,966,000 | +77.5% | 202,954 | +96.3% | 0.00% | +100.0% |
Q4 2017 | $1,671,000 | +81.6% | 103,391 | +57.2% | 0.00% | +100.0% |
Q3 2017 | $920,000 | +131.7% | 65,791 | +46.2% | 0.00% | 0.0% |
Q2 2017 | $397,000 | -0.5% | 45,000 | -27.1% | 0.00% | 0.0% |
Q1 2017 | $399,000 | +565.0% | 61,719 | +235.4% | 0.00% | – |
Q3 2016 | $60,000 | +36.4% | 18,400 | -2.1% | 0.00% | – |
Q2 2016 | $44,000 | -91.6% | 18,800 | -88.9% | 0.00% | -100.0% |
Q4 2015 | $522,000 | +286.7% | 170,134 | +117.5% | 0.00% | – |
Q3 2015 | $135,000 | -85.7% | 78,217 | -66.3% | 0.00% | -100.0% |
Q2 2015 | $943,000 | -4.9% | 232,218 | -10.3% | 0.00% | -50.0% |
Q1 2015 | $992,000 | +103.7% | 258,978 | +155.5% | 0.00% | +100.0% |
Q4 2014 | $487,000 | +711.7% | 101,378 | +608.9% | 0.00% | – |
Q1 2014 | $60,000 | – | 14,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |